3/A

PRIMARY DOCUMENT

Company: GYRE THERAPEUTICS, INC.
Filed: July 27, 2018
Period of Report: July 27, 2018
Accession Number: 0001687888-18-000002

View Document ↗ View on SEC.gov ↗